Vimarsana
Biggest News Aggregation in the World

Taylorb Young News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Taylorb Young. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Taylorb Young Today - Breaking & Trending Today

Promontory Therapeutics to Present Research on the Immunological Effects of PT-112 in Cancer Cell Mitochondria at SITC 2022 - Vimarsana News

Promontory Therapeutics to Present Research on the Immunological Effects of PT-112 in Cancer Cell Mitochondria at SITC 2022

Published: November 7, 2022

NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherap...

Source: businessinsider.com
Related Topics:
United StatesStephanie CarringtonTakahiro YamazakiAlexis FeinbergTaylorb YoungLorenzo GalluzziPromontory Therapeutics IncPrnewswire Promontory Therapeutics IncMerck KgaMerck KgaaVirtual CongressStrategic DevelopmentTherapeutics IncAnnual MeetingPresentation SessionsPromontory TherapeuticDevelopmental TherapeuticsOrphan DrugPromontory Therapeutics
Promontory Therapeutics Reports PT-112's Effects on Human Prostate Cancer Cell Mitochondria at the 34th EORTC-NCI-AACR Symposium - Vimarsana News

Promontory Therapeutics Reports PT-112's Effects on Human Prostate Cancer Cell Mitochondria at the 34th EORTC-NCI-AACR Symposium

Published: October 26, 2022

/PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, reported today new...

Source: prnewswire.com
Related Topics:
United StatesBaja CaliforniaComunidad Autonoma De CatalunaMatthew PriceMark CorbaeStephanie CarringtonAlberto AnelTaylorb YoungPromontory Therapeutics IncNational Cancer InstituteHealth Research InstituteDepartment Of BiochemistryPrnewswire Promontory Therapeutics IncAmerican Association For Cancer ResearchMerck KgaProfessor At University Of Zaragoza AragMerck KgaaVirtual CongressStrategic DevelopmentSymposium Of The European Organisation For ResearchTherapeutics IncEuropean OrganisationAmerican AssociationCancer ResearchCellular Biology
Promontory Therapeutics to Present Research on PT-112 in Prostate Cancer at the 34th EORTC-NCI-AACR Symposium - Vimarsana News

Promontory Therapeutics to Present Research on PT-112 in Prostate Cancer at the 34th EORTC-NCI-AACR Symposium

Published: October 12, 2022

/PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, today announced...

Source: prnewswire.com
Related Topics:
United StatesBaja CaliforniaComunidad Autonoma De CatalunaRuth Soler AgestaMark CorbaeStephanie CarringtonTaylorb YoungPromontory Therapeutics IncNational Cancer InstituteUniversity Of ZaragozaPrnewswire Promontory Therapeutics IncAmerican Association For Cancer ResearchMerck KgaMerck KgaaVirtual CongressStrategic DevelopmentSymposium Of The European Organisation For ResearchTherapeutics IncEuropean OrganisationAmerican AssociationCancer ResearchPresentation SessionCell BiologyPromontory TherapeuticDevelopmental Therapeutics
Promontory Therapeutics Announces Peer-Reviewed Publication in Cancers of Selective Effects of PT-112 in Cancer Cell Models Driven by Mitochondrial Dysfunction - Vimarsana News

Promontory Therapeutics Announces Peer-Reviewed Publication in Cancers of Selective Effects of PT-112 in Cancer Cell Models Driven by Mitochondrial Dysfunction

Published: August 11, 2022

/PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company focused on oncology therapeutics, announced today the peer-reviewed...

Source: prnewswire.com
Related Topics:
United StatesMatthew PriceMark CorbaeStephanie CarringtonTaylorb YoungMerck KgaPromontory Therapeutics IncMerck KgaaVirtual CongressStrategic DevelopmentDevelopmental TherapeuticsOrphan DrugPromontory TherapeuticsPromontory Therapeutics Inc
Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer - Vimarsana News

Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer

Published: May 16, 2022

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Related Topics:
United StatesRegion FlamandeJohan BaeckRobert FallonMark CorbaeStephanie CarringtonJosephf OdonnellTaylorb YoungPromontory Therapeutics IncGlobal Head Of Medical AffairsPrnewswire Promontory Therapeutics IncMerck KgaMerck KgaaAbbott LaboratoriesStrategic DevelopmentClinical DevelopmentTherapeutics IncExecutive Vice PresidentChief MedicalPromontory TherapeuticsJounce TherapeuticsSenior Vice PresidentChief Medical OfficerSenior Medical DirectorPromontory President